Obseva Sa Is A Clinical Stage Biopharmaceutical Company Based In Switzerlandfounded In November 2012The Company Focuses On Developing And Commercializing Therapeutic Solutions For Women S Reproductive Health And Pregnancyspecifically Targeting Women Aged 15 To 49 Obseva Specializes In Creating Oral Compounds For Various Reproductive Health Conditionsits Product Pipeline Includes Linzagolixan Oral Gnrh Receptor Antagonist For Treating Endometriosis And Uterine Fibroidsnolasibanan Oral Oxytocin Receptor Antagonist Aimed At Enhancing Embryo Implantation During Assisted Reproductive Technologiesand Obe022A Selective Pgf2A Receptor Antagonist Designed To Control Preterm Laborobseva Operates Within The Biotechnology And Medical Research Sectors And Is Listed Under The Ticker Symbol Obsefthe Company Has A Small Workforce Of Approximately 15 Employees
No conferences found for this company.
| Company Name | Obseva Sa |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
